ConductScience.org, home

Paper6563941

Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.

de Jong WH and 6 others. Cancer Immunol Immunother, 1984. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches. Papers, record 6563941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6563941

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2024-04-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Jong WHW H
2Steerenberg PAP A
3Kreeftenberg JGJ G
4Tiesjema RHR H
5Kruizinga WW
6van Noorle Jansen LML M
7Ruitenberg EJE J

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
Alanine Transaminase
Animals
Body Temperature
Carcinoma, Squamous Cell
Cell Line
Dose-Response Relationship, Immunologic
Evaluation Studies as Topic
Female
Hypersensitivity, Delayed
Immunization
Killer Cells, Natural
Liver Neoplasms, Experimental
Lung Neoplasms
Lymph Nodes
Lymphoma
Macrophages
Mice
Neoplasms
Organ Size
Rabbits
Skin Tests
Spleen

Source PubMed

Download CSV of topics

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1283275In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice.J Natl Cancer Inst1979https://conductscience.org/library/papers/283275PubMed
37466726Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.Thorax1980https://conductscience.org/library/papers/7466726PubMed
4447557Immunotherapy in ocular equine sarcoid.J Am Vet Med Assoc1979https://conductscience.org/library/papers/447557PubMed
57407781Use of new biologic agents in clinical immunotherapy.Cancer Treat Rep1980https://conductscience.org/library/papers/7407781PubMed
67046801Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system.Biochim Biophys Acta1982https://conductscience.org/library/papers/7046801PubMed
77330812Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.Thorax1981https://conductscience.org/library/papers/7330812PubMed
8608553Proposals for quality control methods of bacterial vaccines for immunostimulation. II. In vivo and in vitro stimulation of lymphocytes by BCG.Dev Biol Stand1977https://conductscience.org/library/papers/608553PubMed
9864757Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine.J Natl Cancer Inst1977https://conductscience.org/library/papers/864757PubMed
10288936Quantitative comparison of BCG strains and preparations in immunotherapy of a rat sarcoma.J Natl Cancer Inst1979https://conductscience.org/library/papers/288936PubMed
11348035Immunotherapy from malignant disease.Annu Rev Med1978https://conductscience.org/library/papers/348035PubMed
126210637Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis.Infect Immun1982https://conductscience.org/library/papers/6210637PubMed
1313909847[Immunological studies with Haemaccel].Dtsch Med Wochenschr1962https://conductscience.org/library/papers/13909847PubMed
146845257Intrapleural Corynebacterium parvum for malignant pleural effusions.Thorax1983https://conductscience.org/library/papers/6845257PubMed
1513995378Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability.Br Med J1962https://conductscience.org/library/papers/13995378PubMed
167029149Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.J Thorac Cardiovasc Surg1981https://conductscience.org/library/papers/7029149PubMed
174587143Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response.J Natl Cancer Inst1973https://conductscience.org/library/papers/4587143PubMed
184373753Differential effects of two strains of BCG on transplantation immunity to SV40-induced tumors in hamsters.Proc Soc Exp Biol Med1974https://conductscience.org/library/papers/4373753PubMed
196928226Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity.J Natl Cancer Inst1980https://conductscience.org/library/papers/6928226PubMed
206344747Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains.Ann Immunol (Paris)1983https://conductscience.org/library/papers/6344747PubMed
216563941Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6563941PubMed

See all 44 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
6563941Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6563941PubMed
3787886The effects of intravesical and intradermal application of a new B.C.G. on the dog bladder.Urol Res1986https://conductscience.org/library/papers/3787886PubMed
3633215Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3633215PubMed
2922891Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig.Urol Res1989https://conductscience.org/library/papers/2922891PubMed
2376047Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2376047PubMed
2337907Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2337907PubMed
2199369Increased activity of FIM in serum of mice during a Mycobacterium bovis (BCG) infection.Immunology1990https://conductscience.org/library/papers/2199369PubMed
1828389Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1828389PubMed
1760813Tumour rejection after adoptive transfer of line-10-immune spleen cells is mediated by two T cell subpopulations.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1760813PubMed
1756535Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1756535PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6563941

GET https://conductscience.org/api/papers/v1/6563941/references?page=2